In this video, Muhammad Gohar Maqbool, MRCP (UK); MRCPE; FRACP; FRCPA, University Hospital Bristol NHS Foundation Trust, Bristol, UK, discusses strategies to reduce the risk of infectious complications in patients treated with CAR-T therapy. First, Dr Gohar Maqbool highlights common prophylactic approaches, including the use of antifungal and antiviral medication, and then goes on to comment on the use of granulocyte colony-stimulating factor (G-CSF) after CAR-T therapy. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.